Showing results (1161-1170 of 1,351) with videos related to

Sort By:
Pageof 136
Haematologica|January 2, 2025
FLI1 and GATA1 govern <i>TLN1</i> transcription: new insights into FLI1-related platelet disordersElisa Gabinaud, Laurent Hannouche, Mathilde Veneziano-Broccia, et al.
Lung Cancer (Amsterdam, Netherlands)|June 24, 2026
Sex disparities in lung cancer: Results of the KBP-2020-CPHG studyDorine Templement-Grangerat, Chrystèle Locher, Anne Catherine Neidhardt, et al.
International Journal of Molecular Sciences|September 10, 2021
An <i>O</i>-GlcNAcylomic Approach Reveals ACLY as a Potential Target in Sepsis in the Young RatManon Denis, Thomas Dupas, Antoine Persello, et al.
Blood|January 17, 2012
A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of functionLubka T Roumenina, Marie Frimat, Elizabeth C Miller, et al.
Nature Communications|July 30, 2024
The bearing capacity of asteroid (65803) Didymos estimated from boulder tracksJ Bigot, P Lombardo, N Murdoch, et al.
Urologic Oncology|September 5, 2025
Peritoneal recurrence following nephrectomy for localized renal cancer: A multicenter European real-world analysis of incidence, pattern and treatment (PEMET study-UroCCR 124)Caroline Pettenati, Jean-Christophe Bernhard, Zine-Eddine Khene, et al.
Plos One|August 30, 2008
Climate warming, marine protected areas and the ocean-scale integrity of coral reef ecosystemsNicholas A J Graham, Tim R McClanahan, M Aaron MacNeil, et al.
European Radiology|July 19, 2023
Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablationRaphaël Lehrer, Francois Cornelis, Jean-Christophe Bernhard, et al.
European Urology Oncology|July 19, 2022
Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell CarcinomaGéraldine Pignot, Antoine Thiery-Vuillemin, Laurence Albigès, et al.
Cell Death & Disease|June 9, 2025
Inhibiting microtubule polymerization with EAPB02303, a prodrug activated by catechol-O-methyl transferase, enhances paclitaxel effect in pancreatic cancer modelsKévin Bigot, Cindy Patinote, Véronique Garambois, et al.
Pageof 136